Lienal Polypeptide Injection is a highly active substance with polypeptides and nucleic acid as the main components which is refined from healthy calf spleen extract. With a molecular weight of less than 6000 Daltons, Spleen polypeptide injection has two patented technologies of component innovation and process innovation.
※ Patent ZL200410088895.5：《Lienal Polypeptide Extract：Preparation Method and Use》
※ Patent ZL201510824919.7：《Method for Preparing Lienal Polypeptide Injection》
※ Patent ZL201610638104.4：《Lienal Polypeptide Injection improve the medical use of KLRK1 or LCK in the treatment of immune inhibition》
A broad application in clinical practice
Lienal Polypeptide Injection has the functions of improving immune function and stimulating bone marrow hematopoiesis, and is widely used in clinical treatment of tumors, infections, blood and other diseases by many departments. It can be used in many departments such as oncology, radiotherapy, biotherapy for various types of tumor patients at various stages, and has the functions of improving the immune injury caused by radiotherapy and chemotherapy, the immune function of the body, and the success rate of radiotherapy and chemotherapy. In the fields of respiration, ICU, emergency, surgery, pediatrics and the like, spleen polypeptide injection promotes the recovery of infection and reduces the recurrence of infection by regulating the body's immune function. Having been widely used in clinical practice, the products are highly recognized by industry experts.
High security
Lienal Polypeptide Injection is highly safe with few adverse reactions. The animal acute toxicity experiment has shown that the maximum tolerance of this product in mice' muscle injection is equivalent to 408.33~1633.33 times of the clinical therapeutic dose.
The medication basis for both children and elderly patients is reflected in the instructions.
Notice：Reference forMedical Professionals Only
